Kidney cancer

Related records

Broader conditions (13)

• Cancer
• Cancer or benign tumor
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Human disease
• Kidney disorder
• Kidney neoplasm
• Malignant urinary system neoplasm
• Neoplasm
• Neoplastic disease or syndrome
• Urinary system disorder
• Urinary system neoplasm

Narrower conditions (72)

• Acquired cystic disease-associated renal cell carcinoma
• Adrenal cortex carcinoma
• Adrenocortical carcinoma, hereditary
• Adult kidney Wilms tumor
• Anaplastic sarcoma of the kidney
• Aniridia 2
• Aniridia 3
• Blastema predominant kidney Wilms tumor
• Carcinoma in situ of renal pelvis
• Cellular congenital mesoblastic nephroma
• Childhood kidney cell carcinoma
• Childhood kidney Wilms tumor
• Childhood malignant kidney neoplasm
• Childhood renal cell carcinoma with MiT translocations
• Chromophobe renal cell carcinoma
• Classic congenital mesoblastic nephroma
• Classic variant of chromophobe renal cell carcinoma
• Clear cell papillary renal cell carcinoma
• Clear cell renal carcinoma
• Clear cell sarcoma of kidney

Trials (997)

• (3D) Ultrasound Imaging Liver and Kidney
• [18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment
• [18F]Fluciclatide PET Imaging of Pazopanib Response
• [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
• 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
• 177LuPSMA in Renal Cell Carcinoma
• 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease
• 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
• 3D Virtual Models as an Adjunct to Preoperative Surgical Planning
• 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer
• 64Cu-GRIP B in Patients With Advanced Malignancies
• 68Ga- and 18F-CAIX PET Imaging Study
• 68Ga-PSMA PET in the Renal Cell Carcinoma
• 9-ING-41 in Patients With Advanced Cancers
• A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...
• A CCafU-UroCCR Randomized Trial: 3D Image-Guided Robot-AssisTEd Partial Nephrectomy for Renal Complex Tumor (UroCCR N°99)
• A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members
• A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties
• A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Drugs in development (179)

• 9-aminocamptothecin Phase 2
• Acarbose Phase 2
• Acetaminophen Phase 2
• Aldesleukin Phase 3
• Alemtuzumab Phase 2
• Alvocidib Phase 2
• Amifostine Phase 1
• Antilymphocyte immunoglobulin (horse) Phase 2
• Antineoplaston A10 Phase 2
• Arsenic trioxide Phase 2
• Atezolizumab Phase 2
• Atorvastatin Phase 2
• Atrasentan hydrochloride Phase 2
• Avelumab Phase 2
• Axitinib Phase 3
• Becatecarin Phase 2
• Benmelstobart Phase 3
• Bevacizumab Phase 3
• Bortezomib Phase 2
• Bryostatin 1 Phase 2

Other linked drugs (2)

• Iodine
• Rocapuldencel-T